InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Edris Badreddin, Chief Operating Officer. Officer active across 3 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 16 reports have been logged. Split: 0 buy · 6 sells. Total volume traded: €5.4m. Activity tracked since 1 July 2021. The latest transaction was filed on 21 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Edris Badreddin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
13,690 shares@ US$0.39100.0% of flowCommon StockSEC:0001786966-26-000001:0
169,712 sharesCommon StockSEC:0001104659-25-065322:0
3,924 shares@ US$53.12182.4% of flowCommon StockSEC:0001104659-25-021008:0
30,000 shares@ US$53.126518.3% of flowCommon StockSEC:0001104659-25-012359:0
27,023 shares0Common StockSEC:0001104659-25-003462:0
6,934 shares@ US$38.193.1% of flowCommon StockSEC:0001104659-25-001768:0
11,966 shares@ US$41.78025.6% of flowCommon StockSEC:0001104659-24-125969:0
12,300 shares@ US$40.11455.3% of flowCommon StockSEC:0001104659-24-096869:0
11,772 shares@ US$39.40155.0% of flowCommon StockSEC:0001104659-24-068673:0
42,312 shares0Common StockSEC:0001104659-24-002374:0
1,483 shares@ US$26.410.4% of flowCommon StockSEC:0001104659-23-002704:0
33,994 sharesCommon StockSEC:0001104659-23-002321:0
1,852 shares@ US$56.061.6% of flowCommon StockSEC:0001104659-22-004462:0
2,531 shares@ US$56.062.1% of flowCommon StockSEC:0001104659-22-003142:0
26,124 sharesCommon StockSEC:0001104659-22-002752:0
32,000 shares@ US$85.346539.0% of flowCommon StockSEC:0001104659-21-088377:0
16 of 16 declarations
About Edris Badreddin
Edris Badreddin is Chief Operating Officer and a declarant with 16 filings in total. In the 16 recent sampled filings, the transactions are sales, for a total of EUR 5399141, between 2021-07-01 and 2026-01-23. The main filings concern SpringWorks Therapeutics, Inc., including EUR 2305447.909517061 on 2021-07-01, EUR 1545630.576349556 on 2025-02-12, EUR 476079.6259554174 on 2024-12-05, EUR 446569.1055870642 on 2024-09-04, EUR 425248.0728856679 on 2024-06-05, and EUR 257892.6400221602 on 2025-01-07.
